Cystic fibrosis (CF) infections are invariably biofilm-mediated and polymicrobial, being safe to assume that a myriad of factors affects the sociomicrobiology within the CF infection site and modulate the CF community dynamics, by shaping their social activities, overall functions, virulence, ultimately affecting disease outcome. This work aimed to assess changes in the dynamics (particularly on the microbial composition) of dual-/threespecies biofilms involving CF-classical (Pseudomonas aeruginosa) and unusual species (Inquilinus limosus and Dolosigranulum pigrum), according to variable oxygen conditions and antibiotic exposure.
Introduction
According to the World Health Organization, infectious respiratory diseases are a major cause of morbidity and mortality worldwide, accounting for 4.18 million premature deaths per year (WHO, 2013) . It is believed that most -if not all -of these infections are associated with biofilms, which represent a critical health-care burden (Bjarnsholt et al., 2013) because of their great contribution to the emergence and dissemination of antibiotic resistance. Cystic fibrosis (CF) is a common heritable genetic disorder (100 000 people estimated to be affected) (Davies et al., 2014) with major debilitation in the respiratory tract, where patients are prone to develop severe biofilm-related infections. CF infection was originally characterized as monomicrobial, likely due to the extensive use of culture-dependent isolation techniques. However, the advent of affordable high-resolution molecular technologies has dramatically changed our view on the true diversity of microbes present in the CF airways (Lopes et al., 2015) . Indeed, the large variety and concentration of microbes includes not only the key pathogens habitually recovered (e.g. Pseudomonas aeruginosa) but also unusual species (e.g. Inquilinus limosus, Stenotrophomonas maltophilia, Dolosigranulum pigrum, Pneumoncystis jirovecii, Scedosporium spp., adenovirus, rhinovirus, etc.) (Bittar et al., 2008; Coenye et al., 2002; Pederiva et al., 2012) . Though that CF aetiology is invariably polymicrobial, most research has focused on specific pathogens, failing to consider the role of unusual microbes in the disease progression Magalhães et al., 2016; Waters, 2012) or their social interactions with established pathogens (Lopes et al., 2012) . Accordingly, I. limosus (a gram-negative aerobe with a very mucoid phenotype) (Coenye et al., 2002) and D. pigrum (a gram-positive, facultative anaerobe, arranged in pairs, tetrads, and clusters) (Aguirre et al., 1993) are less typical bacteria reported in expectorated CF patients (Bittar et al., 2008) . Whilst the pathogenic potential of I. limosus has been already pointed (Chiron et al., 2005) , information on D. pigrum is still limited and its role in CF infection unclear. The upper respiratory tract is thought to be its natural habitat (Laclaire and Facklam, 2000) , but its occurrence in other polymicrobial contexts (Hoedemaekers et al., 2006; Lecuyer et al., 2007) has raise up interest in evaluating its pathogenic potential in CF polymicrobial communities. Interestingly, earlier in vitro studies have unravelling the contribute of I. limosus and D. pigrum for the resilience of CF-associated biofilms to antibiotic treatment Lopes et al., 2012) , thereby allowing to hypothesize their influence in the behaviour of coexisting species or even in benefiting the whole community. It is likely that the multifaceted CF microbiome promotes for species-specific relationships, often necessary for the development and structure of the community and other regulatory activities that coordinate the whole community (Magalhães et al., 2016; TolkerNielsen and Molin, 2000) . In addition, it is now evident that microbial communities can be modulated by a wide variety of other factors that, altogether, give rise to various microbiological scenarios seen in vivo and are likely to affect disease phenotype and the clinical outcome (Guss et al., 2011; Magalhães et al., 2016; Peters et al., 2012a; Stressmann et al., 2011) , as has been determined for other pathologies Azevedo et al., 2016; LiPuma, 2014; Peters et al., 2012b) . For instance, the physicochemical characteristics of the airways; the administration of the antibiotic therapy, (maintenance vs. treatment of episodes of acute exacerbation); the nature of the pre-existing microbial community; the concomitant airway inflammation resulting from chronic infections as well as patient-and/or disease-associated issues (increasing age, disease progression, reduced lung function) have been suggested to have a crucial impact on the dynamics of CF polymicrobial communities (Cuthbertson et al., 2016; KlepacCeraj et al., 2010; Rogers et al., 2015; Serisier, 2013; van der Gast et al., 2014; Willner et al., 2012; Zhao et al., 2012) . Altogether, these factors may drive to social, structural and functional diversification and consequently impact the ecology and evolution in natural species populations (Allen and Banfield, 2005; Schloter et al., 2000) . Although it is still almost impossible to predict biofilm behavior and the dynamics of a community, it is now increasingly recognized that its regulatory networks (e.g. social activities, overall functions, virulence traits, etc.) are often strictly evolved in response to those highly variable stimuli (Allen and Banfield, 2005; Nadell et al., 2016) , and improving and directing efforts to better understand how polymicrobial infections behave and respond to surrounding stresses may give insights to better predict disease progression and to define more effective antimicrobial strategies.
In this scope, this study aimed at deeply investigating the behavior of I. limosus and D. pigrum when associated with the CF-conventional pathogen P. aeruginosa in dual-species and even in three-species populations. The response of these multispecies communities to aerobic (AER) microaerophilic (MAER) and anaerobic (ANAER) conditions resembling the CF airways and to subsequent antibiotic interventions was further examined in detail. Thus, changes in the biofilm-formation ability, antibiotic resistance profiles, bacterial killings, microbial composition and distribution within the multispecies biofilms were assessed.
Material and methods

Bacterial strains and culture conditions
The bacterial strains used in this work were: P. aeruginosa (strain UCBPP-PA14), I. limosus (strain M53, isolated from CF sputum), and D. pigrum (CIP 104051T, purchased from Institute Pasteur Collection, Paris, France). All strains were stored at −70°C in 20% (v/v) glycerol. Prior to inoculation, bacteria were subcultured twice from the frozen stock preparations onto tryptic soy broth (TSB, Liofilchem, Italy) supplemented with 1.2% (w/v) agar (TSA, Liofilchem) plates and incubated at 37°C for 24-48 h.
Formation of multispecies biofilms under variable oxygen conditions
The formation of dual-and three-species biofilms formed by P. aeruginosa, I. limosus and D. pigrum under AER, MAER and ANAER conditions was performed as described elsewhere .
Briefly, for preparing biofilm inocula, several colonies from a fresh subculture of each strain were suspended in TSB to match a 1.0 McFarland standard. This was further diluted in broth medium (TSB) to obtain pure cultures with ∼10 7 cells/mL. For dual-species cultures, the suspended inoculum of each species was combined in a 1:1 ratio, whereas the three-species cultures were obtained by mixing the three pure bacterial suspensions in equal proportions. Bacterial suspensions were dispensed in standard 96-well microtiter plate wells and incubated at 37°C and 120 rpm until achieving the threshold the cell concentration interval of 2 × 10 5 to 2 × 10 6 CFU/cm 2 (determined by previous established biofilm growth curves) . To resemble the oxygen environments of CF airways, plates were incubated at different conditions: AER (n-biotek, Model NB-205Q, Korea incubator), MAER (Thermo Scientific, Forma 311, USA incubator, calibrated with 5% v/v CO 2 ) and ANAER (AnaeroGen Atmosphere Generation system, Oxoid, Cambridge, UK). The ANAER atmosphere was created by sealing the plates containing the cells suspensions in plastic boxes with AnaeroGen sachets (Oxoid), which reduces oxygen concentration to below 1% (v/ v). This oxygen reduction was confirmed by using anaerobic indicator strips (Oxoid) (see Fig. S1 in Supplementary Material).
Quantification of biomass and metabolic activity of biofilms
After biofilm formation, the content of microtiter plate wells (planktonic cell fraction) was discarded, the wells washed once with sterile 0.9% (w/v) saline solution to remove non-adherent and weakly adherent bacteria, and biofilms were quantified for biomass and metabolic activity. Biofilm mass quantification was based on staining biofilms with crystal violet (CV), with protocol adapted from Stepanovic et al. (Stepanovic et al., 2000) . Briefly, the wells were air dried for 10 min before fixing attached bacteria with pure methanol (Fisher Scientific, Leicestershire, UK) for 15 min. Then, biofilms were stained for 1 min with 1% (v/v) CV (Merck, Germany). The excess stain was removed by washing twice the wells with sterile distilled water. Lastly, the bound dye was dissolved in pure methanol (200 μL/well) and the optical density (OD) was read at 550 nm (OD 550nm ) in a microtiter plate reader (Model Sunrise-basic Tecan, Austria).
The metabolic activity of biofilms was measured using the 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2Htetrazolium-5-carboxanilide sodium salt (XTT) colorimetric method, initially described by Stevens and Olsen (Stevens and Olsen, 1993) , with some modifications. Basically, after biofilm growth and washing procedures, 200 μL of a combined solution of XTT (Sigma) and phenazine methosulfate (PMS) (Sigma) were added to each well in order to obtain a final concentration of 150 mg/L of XTT and 10 mg/L of PMS. After that, plates were incubated at 37°C for 3 h in the dark. Biofilm metabolic activity was determined by reading the OD at 490 nm (OD 490nm ) in each well.
Determination of the competitive index (CI) and the relative increase ratio (RIR)
In order to determine whether the species could compete with each other in multispecies biofilms, the Competitive Index (CI) was defined as the X/Y ratio within the output sample (immediately after biofilm formation) divided by the corresponding ratio in the inoculum (input):
where N is the value of CFU/cm 2 obtained for the species X or Y in the biofilm, in the output (at fixed times) and input (t = 0 or the inoculum) sample (Macho et al., 2007) . For statistical analyses, CI values were first subjected to a Log transformation for normal distribution, then interpreted as follows: a CI value equal to 0 indicates equal competition of species X and Y in the consortium; a positive CI value indicates a competitive advantage for the species X; a negative CI value indicates a competitive advantage for the species Y. Similarly, the Relative Increase Ratio (RIR) was calculated and based on the growth results obtained from the single-species biofilms formed by each strain. Calculations were adapted from (Macho et al., 2007) . Statistical significant differences between CI and RIR means for each case were suggestive of a meaningful competition between the species in the consortia.
Biofilm resistance profiles
Antibiotics susceptibilities of biofilms were determined by adapting the protocol described by Ceri et al. (Ceri et al., 1999) . For that, preestablished biofilms (containing 2 × 10 5 to 2 × 10 6 CFU/cm 2 ) formed on the microtiter plate wells were exposed to increasing 2-fold concentrations (ranging from 2 to 1024 mg/L) of 9 clinically-relevant antibiotics: tobramycin (TOB), gentamicin (GEN), levofloxacin (LVF), ciprofloxacin (CIP), clindamycin (CLI), cefotaxime (CTX), chloramphenicol (CAM), rifampicin (RIF) and aztreonam (ATM, all from Sigma), prepared in cation-adjusted Mueller-Hinton broth (C-AMHB). Plates were then incubated at 37°C, under AER, MAER and ANAER environments, as described above. Following 24 h of antibiotic exposure, planktonic cell fractions (supernatant) released for treatedbiofilms were transferred to new microtiter plates and the minimum inhibitory concentrations (MICs) were obtained by reading the OD at 650 nm (OD 650 nm ), where OD 650 nm < 0.1 was evidence of bacterial growth inhibition. Biofilms attached to the wells were rinsed twice with saline solution and disrupted (by sonication with an ultrasound bath) into TSB supplemented with 1% (v/v) tween ® 20 (Fisher Scientific, NJ, USA). The minimum biofilm eradication concentration (MBEC), corresponding to the lowest antibiotic concentration able to inhibit biofilm growth, was determined after plating serial dilutions of disrupted biofilms samples onto TSA.
Assessment of bacterial killings within biofilms after antibiotic exposure
The efficacy of the aforementioned antibiotics at concentrations equal to 2, 128 and 1024 mg/L was evaluated for bacterial killings within biofilms, which was expressed in terms of percentage reduction in biofilm-cell numbers. After biofilms being exposed to antibiotics (as previously described), total cultivable cell numbers were enumerated by plating 10-fold serially diluted biofilm-detached samples onto TSA plates. Biofilm-cell killing was reported as the percentage of log reduction calculated to the relative cell count at the time of initiation of antibiotic exposure, according to the following: Biofilm-cell reduction (%) = 100 − [N (after exposure to the antibiotic)/N (prior to antibiotic exposure) × 100] where N is the value of CFU/cm 2 present in the biofilm determined before or after being exposed to the antibiotic at the desired concentration.
Determination of biofilms composition
In this work, the relative species composition within polymicrobial biofilms was estimated before and after antibiotic exposure. Basically, after the biofilms rinse step, the wells were filled with saline solution (200 μL/well) and biofilms formed in the wells were detached by sonication using an ultrasound bath (Sonicor, model SC-52, UK) operating at 50 kHz, during 10 min and then resuspended by pipetting up and down. The sonication step was previously optimized to ensure that all cells were detached from the wells of the microtiter plate, while avoiding cell disruption (data not shown). The estimation of total biofilms-cells was enumerated by using TSA whereas selective agar media was used to discriminate each bacterial population in the consortia: Pseudomonas isolation agar (PIA; Sigma) and Burkholderia cepacia selective agar, (BCSA; Oxoid Ltd, Hampshire, UK) supplemented with 300 000 IU/L polymyxin B (Biochrom, Berlin, Germany) and 100 mg/L ticarcillin (Sigma) for P. aeruginosa and I. limosus isolation, respectively. Due to the lack of a specific selective medium for D. pigrum, this species was estimated by the difference between the average total cell number (in TSA) and the average of other bacteria presented in the consortia.
Multiplex PNA FISH assay applied to biofilms
In order to discriminate the different populations within the polymicrobial biofilms and to confirm (qualitatively) the results obtained from culture, fluorescence in situ hybridization (FISH) using peptidenucleic acid (PNA) probes followed by an additional staining step with 4', 6-diamidino-2-phenylindole (DAPI; Sigma) was performed directly on polymicrobial consortia. Firstly, biofilms were formed on the surface of Nunc™ Lab-Tek™ II Chamber Slide™ System (Nalge Nunc International; Naperville, IL, USA). After achieving the threshold concentration, biofilms were washed twice with 1 mL of sterilized deionized water and air dried at ∼60°C for 15 min. Biofilms were then fixed with methanol (100% v/v) for 20 min, followed by 4% (w/v) paraformaldehyde and 50% (v/v) ethanol (10 min each), at room temperature. After the fixation step, the surfaces of the chamber slide were covered with 20 μL of hybridization solution with a mixture of two probes at 200 nM and covered with coverslips. These PNA probes, designated Paer565 and Ilim569, were previously developed, optimized and validated in order to specifically detect P. aeruginosa and I. limosus within polymicrobial communities. Hybridization was performed in the dark, for 1 h at 65°C, as determined elsewhere . For washing (65°C for 30 min), a fresh solution composed of 5 mM Tris Base, 15 mM NaCl and 1% (v/v) Triton X-100 (all from Sigma) was prepared less than 24 h before use. Finally, the chamber slides were allowed to air dry in the dark. An additional staining step with DAPI was performed at the end of the hybridization procedure, covering the surfaces with 20 μL of DAPI (40 μg/mL) for 5 min at room temperature in the dark. Then, immediate observation was elaborated in the fluorescence microscope. Negative controls were performed for each experiment, with no probes added to the hybridization solution. For microscopic visualization, a fluorescence microscope (Olympus BX51, Perafita, Portugal) equipped with the filters sensitive to DAPI (BP 365-370, FT 400, LP 421) and to the signaling molecule of the PNA probes (BP 470-490, FT 500, LP 516 and BP 530-550, FT 570, LP 591, for Alexa 488 and 594, respectively) was used.
Statistical analysis
Data were analyzed using the Prism software package (GraphPad Software version 6.0 for Macintosh). Results were compared by oneway analysis of variance (ANOVA) and applying the Tukey multicomparison post-test. Differences were considered statistically significant at P values < 0.05.
Results
Biofilm mass and metabolic activity under different oxygen conditions
In order to inspect for changes in biofilm phenotype under variable oxygen conditions, dual-and three-species biofilms encompassing the CF-associated species I. limosus, D. pigrum and P. aeruginosa were grown under AER, MAER and ANAER environments, being further analyzed in terms of biomass and metabolic activity (Fig. 1 ). An incubation period of 6 h was required for biofilms to achieve the threshold interval (2 × 10 5 to 2 × 10 6 CFU/cm 2 ) as was previously determined by biofilm adhesion kinetics under the selected oxygen conditions (Fig. S2) . Regarding biofilm mass (Fig. 1a) , dual-species biofilms encompassing P. aeruginosa and I. limosus produced the lowest values in comparison with dual-species biofilms of P. aeruginosa and D. pigrum and the consortia involving the three species. The same tendency was observed for the metabolic activity of these biofilms (Fig. 1b) . Overall, biofilms tend to develop significantly less biomass and present lower metabolic activity for limited oxygen conditions, in particular under ANAER (P < 0.05). A particular increase in the metabolic activity was observed for P. aeruginosa and D. pigrum dual-species consortia developed under a MAER environment.
Microbial composition of biofilms under variable oxygen conditions
In order to investigate which bacterial species were prevailing in the biofilms under AER, MAER and ANAER conditions, the relative population distributions were determined by culture (Fig. 2a) . Previously to antibiotic exposure, dual-species biofilms generally presented similar bacterial proportions for all oxygen environments, with P. aeruginosa slightly dominating the overall consortia with I. limosus and occupying similar extents with D. pigrum. Likewise, the three-species biofilms were clearly dominated by P. aeruginosa and D. pigrum, whereas I. limosus was the smallest representative population in the overall biofilm. In order to better discriminate and to infer about changes in the distribution and prevalence of the bacterial populations within the multispecies consortia, a multiplex PNA-FISH counterstained with DAPI was employed directly on biofilms (Fig. 2b) . Overall, FISH images seemed to qualitatively corroborate culture results. In regard to dual-species biofilms, both populations were detected, with P. aeruginosa (red cells) and D. pigrum (blue cells) occupying similar extensions in the consortia, but with P. aeruginosa slightly dominating the dual-species biofilms encompassing I. limosus. Together with D. pigrum, P. aeruginosa still prevailed in the three-species consortia, whereas I. limosus populations were sparsely detected under fluorescence microscopy.
Interspecies competition within biofilms
For a clear understanding of the competition between the species Fig. 1 . Characterization of polymicrobial biofilms formed by P. aeruginosa (PA), I. limosus (IL) and D. pigrum (DP) in terms of (a) biomass and (b) metabolic activity. Biofilms were grown in microtiter plate wells under aerobic (AER), microaerophilic (MAER) and anaerobic (ANAER) atmospheres until achieving the threshold concentration of 2 × 10 5 to 2 × 10 6 CFU/cm 2 (6 h). The means ± SDs for three independent assays are presented. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, AER vs. MAER vs. ANAER, one-way ANOVA with Tukey' post-hoc test. Fig. 2 . Characterization of polymicrobial biofilms formed by P. aeruginosa (PA), I. limosus (IL) and D. pigrum (DP) in terms of (a) microbial compositions and (b) location and distribution of the populations. Biofilms were grown in microtiter plate wells under aerobic (AER), microaerophilic (MAER) and anaerobic (ANAER) atmospheres until achieving the threshold concentration of 2 × 10 5 to 2 × 10 6 CFU/cm 2 (6 h). In (a), the microbial compositions were determined by culture and were expressed as the average of the relative species proportions in the consortia; in (b) a multiplex PNA-FISH assay followed by DAPI staining was applied to the polymicrobial biofilms, in order to discriminate between the populations in the consortia. Images resulted from the bands superposition of the three channels used to visualize the fluorochromes used (Alexa fluor 594, red: PA; Alexa Fluor 488, green: IL; DAPI, blue: DP). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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during biofilm growth under AER, MAER and ANAER environments, the CI and RIR indexes were estimated for dual-and three-species biofilms (Fig. 3) . Whilst CI allows comparing the differences among the growth of each species in mixed cultures, the RIR index compares the growth of species within pure cultures. As shown, a negative CI index was observed for the P. aeruginosa/I. limosus dual-species consortia (Fig. 3a) , meaning a competitive advantage for P. aeruginosa over I. limosus. However, this competition was only significant for AER conditions (CI vs. RIR, P < 0.01). By the contrary, for dual-species consortia involving P. aeruginosa/D. pigrum, the unusual species clearly presented competitive advantage over P. aeruginosa for all oxygen environments (CI > 0; CI vs. RIR, P < 0.0001) (Fig. 3b) . Similarly, when both unusual species were in co-culture with P. aeruginosa (Fig. 3c) , I. limosus was outcompeted by P. aeruginosa (CI < 0), whereas D. pigrum still outcompeted the conventional CF-associated species in the consortia for all oxygen conditions (CI > 0; CI vs. RIR, P < 0.05). Equally, negative CI indexes indicated D. pigrum significantly dominating over I. limosus growth within the three-species consortia under all environments (CI < 0; CI vs. RIR, P < 0.0001).
Other approach to represent these latest results consisted in calculating the relative fitness of P. aeruginosa when co-cultured with the unusual species (Fig. S3 ). This demonstrated enhanced P. aeruginosa fitness when co-cultured with I. limosus and a decline in its performance when D. pigrum is present in the polymicrobial consortia.
Biofilm resistance profiles
The biofilms in the required threshold concentration were exposed to increasing 2-fold concentrations, ranging from 2 to 1024 mg/L, of nine antibiotics. The MICs, obtained from planktonic populations, and the MBECs obtained for biofilm consortia are summarized on Table S1 . Results obtained for mixed-species populations were compared to data obtained from single-species cultures, determined in a previous report of Lopes et al. , where an increase in antibiotic resistance was observed for I. limosus and D. pigrum biofilms. In order to better visualize the tendency for antibiotic tolerance for those populations, two heat maps representing the MIC and MBEC data were generated ( Fig. 4a and b, respectively) . Biofilm-entrapped bacteria showed predictable greater tolerance towards antibiotics than planktonic counterparts, with MBECs (in general ≥ 1024 mg/L) higher than MICs, independently from the oxygen concentration. For planktonic and biofilm cultures, the activity of most antibiotics was preserved under environments defective in oxygen. Specifically, as aminoglycoside uptake is severely limited in Gram-negative and Gram-positive bacteria under oxygen-restricted environments (Hancock, 1962; Kogut et al., 1965; Kohanski et al., 2010) , is therefore indicative that oxygen in the environment (used as the electron acceptor) is the motive force available to assit the aminoglycoside uptake and maintain sensitive under anaerobic conditions (it was the case of P. aeruginosa).
Comparing with monospecies planktonic cultures, polymicrobial populations remained sensitive for most antibiotic agents, with exception for CLI and RIF, which were ineffective in inhibiting those The results are shown as mean ± SDs. **P < 0.01, ***P < 0.001, ****P < 0.0001, CI vs. RIR, one-way ANOVA with Tukey' post-hoc test.
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International Journal of Medical Microbiology 307 (2017) [460] [461] [462] [463] [464] [465] [466] [467] [468] [469] [470] populations (MBEC > 1024 mg/L). When encased in biofilms, the unusual species showed high resistance for most antibiotics, which endured when these species were co-cultured with P. aeruginosa, independently of the oxygen condition.
Effect of antibiotics in reducing biofilm cells
Since MBECs were generally high, it was interesting to address how increasing antibiotic concentrations (at 2, 128 and 1024 mg/L) could affect the viability of bacterial populations within the polymicrobial biofilms (Fig. 5 ). For this, the percentage reduction in total biofilm-cells was estimated by counting bacteria on TSA after exposing biofilms to antibiotics and the results compared from those of un-treated biofilms. Overall, biofilm-cells declined gradually with increasing doses of antibiotics, with the highest concentrations leading to the highest reductions. A clear loss of activity for many antibiotics under low-oxygen atmospheres was also observed, with no visible cell reductions. This was particularly true for P. aeruginosa/I. limosus dual-species biofilms, which showed higher antibiotic resistance under ANAER conditions, with biofilm-cell reduction percentages not exceeding 10% (achieved for GEN). Biofilms encompassing D. pigrum were more sensitive than the previous ones, being markedly noticeable for the consortia involving the three-species, where antibiotics could achieve great bacterial reductions within the biofilms and even with fluoroquinolones (LVF and CIP) leading to the complete eradication for MAER and ANAER environments.
Microbial composition of polymicrobial biofilms after antibiotic treatment
The relative populations proportions of the polymicrobial biofilms after antibiotic exposure was monitored by culture (Fig. 6) . After the antibiotic treatment, substantial changes in the composition of the polymicrobial communities occurred compared with non-treated biofilms (i.e. biofilms pre-exposed to antibiotics), with fluctuations depending on the type and on the concentration of the antibiotic and even on the oxygen conditions. P. aeruginosa/I. limosus dual-species biofilms were still predominately governed by the CF-classical species, particularly under AER conditions (Fig. 6a) . However, I. limosus populations started to occupy a significant proportion, together with P. aeruginosa, for environments of low oxygen tension (MAER and ANAER). Similarly, P. aeruginosa prevailed within the P. aeruginosa/D. pigrum dual-species consortia (Fig. 6b) , persisting alone for many cases. For a vast number of situations, D. pigrum was able to persist and inhabit nearly half part of the whole consortia, together with P. aeruginosa. Changes in the microbial composition of three-species biofilms showed to be quite complex and variable compared with dual-species consortia (Fig. 6c) . A clear dominance of the three-species consortia was typically obtained for D. pigrum and/or P. aeruginosa, whilst I. limosus populations rapidly declining.
Discussion
The recent explosion of large-scale studies has significantly enhanced our appreciation on the true complexity and diversity of the CF multispecies communities. Indeed, the airways and lungs of CF patients are often heterogeneous systems enclosing gradients of antibiotics, nutrients, and oxygen (Yang et al., 2011) , which have been documented as significant factors driving to the diversification at the community level (Cuthbertson et al., 2016; Goddard et al., 2012; Lee et al., 2014; Quinn et al., 2016; Rogers et al., 2015; van der Gast et al., 2014; van der Gast et al., 2011; Zhao et al., 2012) .
Our findings demonstrated that CF polymicrobial communities were not static populations, with biofilm dynamics evolving in response to . The heatmaps were created by using Seaborn, a Python visualization library.
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International Journal of Medical Microbiology 307 (2017) 460-470 environments with distinct oxygen availabilities and to antibiotic therapy. Minimal fluctuations were detected before antibiotic exposure, particularly in terms of biofilm composition. In fact, I. limosus and D. pigrum were proficient to establish biofilms together with the CF emblematic pathogen P. aeruginosa under AER, MAER and ANAER environments with slight variations in biomass and metabolic activity. Earlier studies have shown that both unusual species were able to develop single-species biofilms under these oxygen environments, even showing resistance to multiple antibiotics under those conditions. Several reasons were pointed out to substantiate the underlying antibiotic resistance for both species, which was particularly attributed to the mucoid physiology of I. limosus and to the high biomass achieved for D. pigrum biofilms, associated to the dense extracellular polymeric matrix.
It is important to note that co-infections with equal ratios of P. aeruginosa and the unusual organisms selected may never occur in a CF lung, but it is possible that all strains might reside in the airways of patients for identical lengths in time. Strains of P. aeruginosa, I. limosus and D. pigrum were recovered from CF exacerbations from one geographical region over a period of just 2 months, which suggests that they may encounter each other in their natural microhabitat (Bittar et al., 2008) , eventually not as a stable but as a transient community consequently derived from shifts within the natural environment (Conrad et al., 2013) . While applying PNA-FISH assay to discriminate in situ the bacterial populations within the biofilms, culture results were corroborated by microscopy. An exception was observed for P. aeruginosa/I. limosus dual biofilms, where the sparse distribution of I. limosus indicated a lower prevalence in the consortium. Only an ex situ quantitative monitoring of bacterial populations should better clarify this issue. Polymicrobial biofilms were minimally challenged by variable oxygen conditions. Whilst dual-species biofilms (in particular P. aeruginosa and D. pigrum) presented similar relative proportions for both populations, the three-species biofilms were dominated by P. aeruginosa, with D. pigrum also presenting a great extension together with the CF-traditional species. PNA-FISH and culture assays, complemented with CI and RIR data seems to indicate that D. pigrum/I. limosus and D. pigrum/P. aeruginosa interplay was likely negative, with D. pigrum taking competitive advantage against the other species, thus eventually suggesting competition for the same niche or for nutrients (Hibbing et al., 2010) .
If biofilm dynamics was minimally disturbed with oxygen conditions, treatment with antibiotics had huge impact on multispecies diversification. First, biofilms demonstrated high resistance towards most antibiotics compared with respective planktonic cells, which is consistent with the commonly accepted notion that biofilm-grown bacteria display enhanced resistance to antibiotics, compared to their planktonic counterparts (Costerton et al., 1999; Hoiby et al., 2010; Lopes et al., 2012; Mah and O'Toole, 2001 ). This work, thus, supports that the antibiotic resistance previously demonstrated for I. limosus and D. pigrum endured even in co-culture with P. aeruginosa, thus strongly emphasizing the impact that those species may have on CF antibiotic treatment and pathogenesis. Second, even presenting higher MBECs, the antibiotics could lead to significant reductions in the viability of bacterial populations within the polymicrobial biofilms. The decline in the cell viability was less noticed for treatments challenged under ANAER conditions, with a great number of antibiotics losing S.P. Lopes et al. International Journal of Medical Microbiology 307 (2017) 460-470 their effectiveness under oxygen-limited environments. Third, the composition of polymicrobial biofilms was dramatically challenged by antibiotic therapy, with fluctuations depending on the type and concentration of the antibiotic applied and on the oxygen environment. But whatever the antibiotic and concentration applied, it tends to select for P. aeruginosa rather than for the unusual species. Changes were in general mainly reflected on the relative proportions of I. limosus and/or D. pigrum, with P. aeruginosa as the eminent organism for most cases. In turn, changes on biofilms composition instigated by antibiotic therapy could shape the overall function of the polymicrobial consortia. As an example, P. aeruginosa/I. limosus dual-species consortia were equally distributed within the biofilm (as showed by culture), mainly under ANAER conditions. The demonstrated endurance of I. limosus populations may indicate that this species was potentially the organism that conferred resistance to the overall biofilm when challenged under low oxygen tensions (observed by bacterial killing assays). We therefore suggest that the enhanced sensitiveness of the three-species consortia can be related with the clear decline in the I. limosus population size, with the overall consortia being dominated by P. aeruginosa and D. pigrum. This remarks the competition between both unusual species, with D. pigrum likely disturbing the numbers of the organism that originally had conferred resistance to the dual-biofilm (mainly under depleted oxygen conditions) and leading to more susceptible mixed-species biofilms for a great number of antibiotics, as demonstrated by killing kinetics assays. Taken together, these results can open novel ways for CF treatment, by disturbing one factor that regulates the microbial community (in terms of stability, function and/or antibiotic-resistance) to facilitate subsequent control of the overall community by antibiotics. Aware that rather than a single process, a myriad of variants is responsible for impacting the dynamics of polymicrobial communities in CF natural settings, leading to different scenarios seen in vivo, we were able to reach a model representing how oxygen environments and antibiotic therapy affect the composition of polymicrobial biofilms in CF airways (Fig. 7) . For this, we focused our model in the three-species consortia due to their higher complexity comparable with dual-species biofilms. Prior to antibiotic exposure (Fig. 7a) , minor fluctuations occur across oxygen gradients, with the three-species consortia being dominated by P. aeruginosa (red cells) and D. pigrum (blue) and with I. limosus (green) as the lowest representative population. When biofilms are exposed to antibiotics commonly used to treat P. aeruginosa infections in CF (Doring et al., 2012) , diversification among biofilms is evident (Fig. 7b) , with variable fluctuations occurring in the relative proportions of the resident species depending on the antibiotic and on the oxygen conditions. S.P. Lopes et al. International Journal of Medical Microbiology 307 (2017) 460-470 We are aware that this biofilm model embraces a few limitations (e.g. it is an in vitro model, based on culture experiments complemented with PNA-FISH; it embodies a mixture of three species rather than the full diversity and abundance of microbes in CF and hence dismisses other species with potential huge impact for CF infection). Nonetheless, it reflects how spatially heterogeneous and distributed are CF communities within the site of infection, likely affecting the virulence of the encased pathogens and being a great predictor of disease progression and outcome (Stacy et al., 2016) . It is therefore plausible that discerning the mechanisms that govern CF sociomicrobiology will impair, for instance, that treatment regimens often applied to specific populations may be ineffective against infections occurring in particular regions or microenvironments of the lung/airways. Additionally, it may lead to the development of rationales for the selection of suitable and personalized therapeutic strategies (targeting microbiomes unique to each individual), hence increasing antibiotic therapy and reducing socioeconomic repercussion often associated to inadequate treatments.
Conclusion
This study expanded the understanding about how the dynamics of microbial communities involving CF classical and unusual organisms is collectively influenced by perturbations often common in the CF natural environments. In fact, our results led to conclude that chemical stress is more "aggressive" than environmental stress in modulating the dynamics of CF polymicrobial communities. While the benefits of antibiotic therapy are indisputable, antibiotics may exert dramatic fluctuations on biofilms, thereby shaping resident species composition and affecting overall function of the consortia. In parallel, this study highlights that the presence of unusual species in the CF airways communities should not be disregarded, since they are able to mediate social interactions, affecting the whole community and ultimately modifying the clinical course of the disease. As such, a more deep appreciation of the ecological and evolutionary nature that shape the airways communities as well as their effects on lung will be certainly useful for the optimal use of current therapies and the development of newer breakthroughs on CF antibiotic therapy. 
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